Grantham, Mayo, Van Otterloo & Co (GMO)
SRDX

Grantham, Mayo, Van Otterloo & Co (GMO)’s Surmodics SRDX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,800
Closed -$949K – 929
2020
Q4 		$949K Sell
21,800
-13,500
-38% -$531K 0.01% 575
2020
Q3 		$1.37M Buy
35,300
+18,300
+108% +$804K 0.01% 465
2020
Q2 		$735K Buy
+17,000
New +$643K 0.01% 580

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SRDX Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Surmodics (SRDX) in Q1 2021, closing a stake of 21,800 shares — an estimated $949K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SRDX in Q2 2020 and held it in 3 quarters. The position peaked at $1.37M in Q3 2020. 138 funds tracked by Wall St. Rank hold SRDX as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Surmodics position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,800 Surmodics shares in Q1 2021, an estimated $949K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Surmodics in Q2 2020 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Surmodics position peaked at $1.37M in Q3 2020.
  • 138 funds tracked by Wall St. Rank held Surmodics as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.